Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
30.25
+0.23 (0.77%)
At close: May 16, 2025, 4:00 PM
28.80
-1.45 (-4.79%)
After-hours: May 16, 2025, 7:45 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $1.97 billion as of May 16, 2025. Its market cap has decreased by -4.51% in one year.
Market Cap
1.97B
Enterprise Value
1.28B
1-Year Change
-4.51%
Ranking
Category
Stock Price
$30.25
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $1.97B, an increase of 136.06%. That is a compound annual growth rate of 19.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 1.95B | -24.97% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.30B |
| Johnson & Johnson | 364.23B |
| AbbVie | 323.11B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 261.69B |
| Abbott Laboratories | 234.51B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |